L-Arginine/nitric oxide pathway in chronic tension-type headache: Relation with serotonin content and secretion and glutamate content

Journal of the Neurological Sciences

Volumn 198, Issue 1-2, 2002, Pages 9-15

  Sarchielli, Paola ^a   Alberti, Andrea ^a   Floridi, Ardesio ^a   Gallai, Virgilio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Calcium; Central sensitization; Chronic tension type headache; Cyclic guanosine 3 ,5 monophosphate cGMP; Glutamate; Nitric oxide; Platelets; Serotonin

Indexed keywords

ARGININE; CALCIUM; COLLAGEN; CYCLIC GMP; GLUTAMIC ACID; METHEMOGLOBIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYHEMOGLOBIN; SEROTONIN;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CELL LEVEL; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TENSION HEADACHE; THROMBOCYTE AGGREGATION; UPREGULATION; BLOOD; CHRONIC DISEASE; DRUG EFFECT; METABOLISM; MIDDLE AGED; REFERENCE VALUE; THROMBOCYTE;

ADULT; ARGININE; BLOOD PLATELETS; CALCIUM; CHRONIC DISEASE; COLLAGEN; CYCLIC GMP; CYTOSOL; FEMALE; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PLATELET AGGREGATION; REFERENCE VALUES; SEROTONIN; TENSION-TYPE HEADACHE;

EID: 0037098677     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00035-7     Document Type: Article

References (28)

1. Ashina M., Lassen L.H., Bendtsen L., Jensen R., Olesen J. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet. 353(9149):1999;287-289.
2. Ashina M., Bendtsen L., Jensen R., Lassen L.H., Sakai F., Olesen J. Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain. 122(Pt 9):1999;1629-1635.
3. Ashina M., Bendtsen L., Jensen R., Olesen J. Nitric oxide - induced headache in patients with chronic tension-type headache. Brain. 123(Pt 9):2000;1830-1837.
4. D'Andrea G., Cananzi A.R., Perini F., Hasselmark L. Platelet models and their possible usefulness in the study of migraine pathogenesis. Cephalalgia. 15(4):1995;265-271.
5. Radomski M.W., Palmer R.M., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci.U.S.A. 87(13):1990;5193-5197.
6. 2+, and serotonin content in platelets from patients suffering from chronic daily headache. Cephalalgia. 19(9):1999;810-816.
7. Headache Classification Committee of the International Headache Society Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 8(Suppl. 7):1988;1-96.
8. Silberstein S.D., Lipton R.B., Solomon S., Mathew N.T. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache. 34(1):1994;1-7.
9. Silberstein S.D., Lipton R.B., Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology. 47(4):1996;871-875.
10. Born G.V.R., Cross M.J. The aggregation of blood platelets. J. Physiol. 168:1963;178-195.
11. 2+ mobilization in human platelets. Br. J. Pharmacol. 106(4):1992;966-971.
12. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260(6):1985;3440-3450.
13. Zecca L., Ferrario P. Determination of neurotransmitter amino acids by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 337(2):1985;391-396.
14. Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 52(2):1993;127-136.
15. Hao J.X., Xu X.J. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors. Pain. 66(2-3):1996;313-319.
16. Hoskin K.L., Bulmer D.C., Goadsby P.J. Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME. Neurosci. Lett. 266(3):1999;173-176.
17. Kitto K.F., Haley J.E., Wilcox G.L. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett. 148(1-2):1992;1-5.
18. Bendtsen L. Central sensitization in tension-type headache-possible pathophysiological mechanisms. Cephalalgia. 20(5):2000;486-508.
19. Bendtsen L., Jensen R., Hindberg I., Gammeltoft S., Olesen J. Serotonin metabolism in chronic tension-type headache. Cephalalgia. 17(8):1997;843-848.
20. Bendtsen L., Mellerup E.T. The platelet serotonin transporter in primary headaches. Eur. J. Neurol. 5(3):1998;277-282.
21. Srikiatkhachorn A., Anthony M. Platelet serotonin in patients with analgesic-induced headache. Cephalalgia. 16(6):1996;423-426.
22. Kudrow L. Possible mechanisms and treatment of analgesic-induced chronic headache. Diener H.C., Wilkinson M. Drug-induced headache. 1988;157-161 Springer-Verlag, Berlin.
23. Srikiatkhachorn A., Tarasub N., Govitrapong P. Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache. 40(5):2000;343-350.
24. Cananzi A.R., D'Andrea G., Perini F., Zamberlan F., Welch K.M. Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia. 15(2):1995;132-135.
25. Harris J.A., Corsi M., Quartaroli M., Arban R., Bentivoglio M. Upregulation of spinal glutamate receptors in chronic pain. Neuroscience. 74(1):1996;7-12.
26. Baranauskas G., Nistri A. Sensitization of pain pathways in the spinal cord: cellular mechanisms. Prog. Neurobiol. 54(3):1998;349-365.
27. Felsby S., Nielsen J., Arendt-Nielsen L., Jensen T.S. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain. 64(2):1996;283-291.
28. Urban M.O., Gebhart G.F. Central mechanisms in pain. Med. Clin. North Am. 83(3):1999;585-596.